Increased Production of Leukocyte Microparticles with Enhanced Expression of Adhesion Molecules from Activated Polymorphonuclear Leukocytes in Severely Injured Patients
- 1 January 2003
- journal article
- research article
- Published by Wolters Kluwer Health
- Vol. 54 (1) , 114-120
- https://doi.org/10.1097/00005373-200301000-00014
Abstract
Background Polymorphonuclear leukocyte (PMNL)-derived microparticles (MPs) have been recently reported as activators of vascular endothelium in vitro. The objectives of the present study were to evaluate the production of MPs in severely injured patients and to clarify the role of these MPs. Methods Thirty severely injured patients (mean Injury Severity Score of 27 ± 11) and 21 healthy volunteers participated in the study. Blood samples were obtained serially at three time points: days 0 to 1, days 2 to 5, and days 6 to 12 after the trauma event. MP production, CD11b and CD62L expression on MPs, and oxidative activity in PMNLs were measured by flow cytometry in both the presence and absence of formylmethionyl-leucyl-phenylalanine. Expressions of CD11b and CD62L were differentially evaluated according to the size of the MPs (≥ or < 1.0 μm). Soluble E-selectin and thrombomodulin levels in blood, variables representative of systemic vascular endothelial damage, were also measured. Results Production of MPs with and without formylmethionyl-leucyl-phenylalanine and the oxidative activity in PMNLs (O2−) were prominently increased on days 2 to 5 after trauma. CD62L expression was enhanced on MPs at all three time points, and CD11b expression was enhanced on MPs < 1.0 μm in diameter at all three time points. Soluble E-selectin and thrombomodulin in blood did not change significantly between time points. Conclusion Activated PMNLs enhance production of PMNL-derived MPs with increased adhesion molecule expression on days 2 to 5 after severe trauma. This response per se, however, may not progress to systemic vascular endothelial damage.Keywords
This publication has 25 references indexed in Scilit:
- Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritisArthritis & Rheumatism, 2002
- Detection of monocyte-derived microparticles in patients with Type II diabetes mellitusDiabetologia, 2002
- Assessment of In Vitro-Generated Platelet Microparticles Using a Modified Flow Cytometric StrategyThrombosis Research, 2001
- Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active diseaseBritish Journal of Haematology, 2001
- Leukocyte Microparticles Stimulate Endothelial Cell Cytokine Release and Tissue Factor Induction in a JNK1 Signaling PathwayJournal of Biological Chemistry, 1999
- In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulantJournal of Clinical Investigation, 1999
- Priming, Second-Hit Priming, and Apoptosis in Leukocytes from Trauma PatientsThe Journal of Trauma: Injury, Infection, and Critical Care, 1999
- Cytokines and Adhesion Molecules in Elective and Accidental Trauma-Related Ischemia/ReperfusionThe Journal of Trauma: Injury, Infection, and Critical Care, 1998
- Platelet Microparticles: A Carrier of Platelet-Activating Factor?Biochemical and Biophysical Research Communications, 1996
- Evolving Concepts in the Pathogenesis of Postinjury Multiple Organ FailureSurgical Clinics of North America, 1995